Standards of practice in transarterial radioembolization

CardioVascular and Interventional Radiology

Volumn 36, Issue 3, 2013, Pages 613-622

  Mahnken, Andreas H ^a   Spreafico, Carlo ^b   Maleux, Geert ^c   Helmberger, Thomas ^d   Jakobs, Tobias F ^e  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d KLINIKUM BOGENHAUSEN   (Germany)

^e KRANKENHAUS BARMHERZIGE BRÜDER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE; FLUOROURACIL; YTTRIUM 90;

ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT INJURY; CHOLECYSTECTOMY; CHOLECYSTITIS; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; CONSERVATIVE TREATMENT; DIGESTIVE SYSTEM ULCER; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTERVENTIONAL RADIOLOGY; LIVER CELL CARCINOMA; LIVER METASTASIS; LUNG SHUNTING; MEDICAL PRACTICE; NONHUMAN; OUTCOME ASSESSMENT; PANCREATITIS; PATIENT CARE; PATIENT SAFETY; PORTAL HYPERTENSION; POSTRADIOEMBOLIZATION SYNDROME; PRIORITY JOURNAL; RADIATION EQUIPMENT; RADIATION INDUCED LIVER DISEASE; RADIATION INJURY; RADIATION PNEUMONIA; TRANSARTERIAL RADIOEMBOLIZATION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; HUMANS; LIVER NEOPLASMS; MICROSPHERES; RADIOGRAPHY, INTERVENTIONAL; RADIOTHERAPY DOSAGE; YTTRIUM RADIOISOTOPES;

EID: 84877785257     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-013-0600-8     Document Type: Article

References (56)

1. Jemal A, Bray F, Center MM et al. (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. Davies JM, Goldberg RM (2011) Treatment of metastatic colorectal cancer. Semin Oncol 38:552-560
3. Dawson LA, McGinn CJ, Normolle D et al. (2000) Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 18:2210-2218
4. Dawson LA, Normolle D, Balter JM et al. (2002) Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53:810-821
5. Ariel IM, Pack GT (1966) The treatment of cancer metastases in the lung by means of radiating microspheres. Thoraxchir Vask Chir 14:286-307
6. Simon N, Siffert R, Baron MG et al. (1968) Preoperative irradiation of osteogenic sarcoma with intra-arterially injected yttrium-90 microspheres. Case report. Cancer 21:453-455
7. Blanchard RJ, LaFave JW, Kim YS (1965) Treatment of patients with advanced cancer using Y-90 microspheres. Cancer 18:375-380
8. Mantravadi RV, Spigos DG, Tan WS et al. (1982) Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology 142:783-786
9. Wollner I, Knutsen C, Smith P et al. (1988) Effects of hepatic arterial yttrium 90 glass microspheres in dogs. Cancer 61:1336-1344
10. Shepherd FA, Rotstein LE, Houle S et al. (1992) A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer 70:2250-2254
11. Sacks D, McClenny TE, Cardella JF, Lewis CA (2003) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14:S199-S202
12. Van den Eynde M, Flamen P, El Nakadi I et al. (2008) Inducing resectability of chemotherapy refractory colorectal liver metastasis by radioembolization with yttrium-90 microspheres. Clin Nucl Med 33:697-699
13. Kennedy A, Nag S, Salem R et al. (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68:13-23
14. Iñarrairaegui M, Thurston KG, Bilbao JI et al. (2010) Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 21:1205-1212
15. Stacul F, van der Molen AJ, Reimer P, Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) et al. (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21:2527-2541
16. Bush WH Jr (1999) Treatment of acute contrast reactions. In: Bush WH Jr, Krecke KN, King BF Jr et al. (eds) Radiology Life Support. Oxford University Press, New York, pp 31-51
17. Liu DM, Salem R, Bui JT et al. (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16:911-935
18. Wright CL, Werner JD, Tran JM et al. (2012) Radiation pneumonitis following yttrium-90 radioembolization: case report and literature review. J Vasc Interv Radiol 23:669-674
19. 90Y-microsphere selective internal radiation treatment. J Nucl Med 51:1206-1212
20. Seidensticker R, Seidensticker M, Damm R et al. (2012) Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach. Cardiovasc Intervent Radiol 35:1109-1118
21. Salem R, Lewandowski RJ, Gates VL, Technology Assessment Committee; Interventional Oncology Task Force of the Society of Interventional Radiology et al. (2011) Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol 22:265-278
22. Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52-60
23. 90Y selective internal radiation therapy plus chemotherapy. Eur J Nucl Med Mol Imaging 38:1289-1295
24. Vente MA, Wondergem M, van der Tweel I et al. (2009) Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol 19:951-959
25. Salem R, Lewandowski RJ, Mulcahy MF et al. (2010) Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 138:52-64
26. Sangro B, Carpanese L, Cianni R, European Network on Radioembolization with Yttrium-90 Resin Microspheres (ENRY) et al. (2011) Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. Hepatology 54:868-878
27. Hilgard P, Hamami M, Fouly AE et al. (2010) Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology 52:1741-1749
28. 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 47:71-81
29. Lance C, McLennan G, Obuchowski N et al. (2011) Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol 22:1697-1705
30. D'Avola D, Lñarrairaegui M, Bilbao JI et al. (2009) A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma. Hepatogastroenterology 56:1683-1688
31. Salem R, Lewandowski RJ, Kulik L et al. (2011) Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 140:497-507
32. Gray B, Van Hazel G, Hope M et al. (2001) Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12:1711-1720
33. Van Hazel G, Blackwell A, Anderson J et al. (2004) Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88:78-85
34. Hendlisz A, Van den Eynde M, Peeters M et al. (2010) Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. J Clin Oncol 28:3687-3694
35. Hong K, McBride JD, Georgiades CS et al. (2009) Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. J Vasc Interv Radiol 20:360-367
36. Riaz A, Lewandowski RJ, Kulik LM et al. (2009) Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol 20:1121-1130
37. Salem R, Parikh P, Atassi B et al. (2008) Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol 31:431-438
38. Murthy R, Brown DB, Salem R et al. (2007) Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol 18:553-561
39. Kennedy AS, McNeillie P, Dezarn WA et al. (2009) Treatment parameters and outcome in 680 treatments of internal radiation with resin (90)Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys 74:1494-1500
40. 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65:412-425
41. 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients. ANZ J Surg 76:696-703
42. 90Y microspheres - safety, efficacy, and survival. Radiology 247:507-515
43. Mulcahy MF, Lewandowski RJ, Ibrahim SM et al. (2009) Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer 115:1849-1858
44. Cosimelli M, Golfieri R, Cagol PP, Italian Society of Locoregional Therapies in Oncology (SITILO) et al. (2010) Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer 103:324-331
45. Evans KA, Richardson MG, Pavlakis N et al. (2010) Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres. J Vasc Interv Radiol 21:1521-1526
46. Chua TC, Bester L, Saxena A, Morris DL (2011) Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases. J Cancer Res Clin Oncol 137:865-873
47. 90Y radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg 247:1029-1035
48. 90Y- microspheres: early results in 148 patients. Am J Clin Oncol 31:271-279
49. King J, Quinn R, Glenn DM et al. (2008) Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 113:921-929
50. Saxena A, Chua TC, Bester L et al. (2010) Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases. Ann Surg 251:910-916
51. Cao CQ, Yan TD, Bester L et al. (2010) Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases. Br J Surg 97:537-543
52. Paprottka PM, Hoffmann RT, Haug A et al. (2012) Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres. Cardiovasc Intervent Radiol 35:334-342
53. Jakobs TF, Hoffmann RT, Fischer T et al. (2008) Radioembolization in patients with hepatic metastases from breast cancer. J Vasc Interv Radiol 19:683-690
54. Coldwell DM, Kennedy AS, Nutting CW (2007) Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer. Int J Radiat Oncol Biol Phys 69:800-804
55. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival. J Vasc Interv Radiol 18:621-628
56. Gonsalves CF, Eschelman DJ, Sullivan KL et al. (2011) Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience. AJR Am J Roentgenol 196:468-473